Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Caraway

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Q3
    Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Q3

    13 Jul 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/07/13/2262052/0/en/Meridian-Bioscience-Announces-Preliminary-Revenue-Results-for-Fiscal-2021-Third-Quarter.html

    GLOBENEWSWIRE
    13 Jul 2021
    Share Share
    Meridian Resubmits Application to FDA for EUA for Revogene
    Meridian Resubmits Application to FDA for EUA for Revogene

    28 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/28/2253997/0/en/Meridian-Resubmits-Application-to-FDA-for-Emergency-Use-Authorization-for-Revogene-SARS-CoV-2-Molecular-Assay.html

    GLOBENEWSWIRE
    28 Jun 2021
    Share Share
    AbbVie nabs option for Caraway's preclinical Parkinson's programme
    AbbVie nabs option for Caraway's preclinical Parkinson's programme

    09 Jun 2021

    // A. A. Idrus FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/abbvie-snags-another-preclinical-parkinson-s-program-17m-caraway-pact

    A. A. Idrus FIERCEBIOTECH
    09 Jun 2021
    Share Share
    Caraway Therapeutics Establishes Collaboration with AbbVie
    Caraway Therapeutics Establishes Collaboration with AbbVie

    09 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210609005050/en

    BUSINESSWIRE
    09 Jun 2021
    Share Share
    FDgard® shows Excellent Safety And Tolerability Profile for Functional Dyspepsia
    FDgard® shows Excellent Safety And Tolerability Profile for Functional Dyspepsia

    28 Oct 2019

    // PR NEWS WIRE

    https://www.prnewswire.com/news-releases/in-the-longest-running-post-marketing-surveillance-study-of-its-type-data-at-24-months-on-fdgard-presented-at-the-american-college-of-gastroenterology-acg-annual-meeting-confirms-excellent-safety-and-tolerability-profile-of--300946011.html

    PR NEWS WIRE
    28 Oct 2019
    Share Share